Trust Chemists and Druggists Private Limited has raised equity
December 2023 — Trust Chemists and Druggists Private Limited has successfully completed an equity raise.
Founded in 2003, Trust Chemists and Druggists operates one of the largest hospital pharmacy chains in India. Specializing in managing in-hospital pharmacies, the company operates 47 in-hospital stores and 14 standalone stores across Karnataka, Tamil Nadu and Andhra Pradesh. It offers a one-stop shop for all medicines and wellness needs.
Our role in the transaction
Oaklins’ team in India provided strategic and financial advisory services throughout this transaction. The team onboarded an investor, a family office, adding strategic value and contributing to financial growth. This investor acquired a 26% fully diluted stake in the investee.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Aprenda másKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Aprenda másGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Aprenda más